W, S., V, P., B, H., & M, V. (2025). Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics. Pharmaceuticals (Basel, Switzerland), 18(4), . https://doi.org/10.3390/ph18040522
Chicago Style (17th ed.) CitationW, Serumula, Pillay V, Hadebe B, and Vorster M. "Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics." Pharmaceuticals (Basel, Switzerland) 18, no. 4 (2025). https://doi.org/10.3390/ph18040522.
MLA (9th ed.) CitationW, Serumula, et al. "Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 4, 2025, https://doi.org/10.3390/ph18040522.
Warning: These citations may not always be 100% accurate.